Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas A Turner

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Infectious Disease Clinics of North America|August 9, 2025
Infection Prevention Approaches for Clostridioides difficileJesse Vance, Nicholas A Turner
Clinics in Colon and Rectal Surgery|February 28, 2020
Hospital Infection Control: <i>Clostridioides difficile</i>Nicholas A Turner, Deverick J Anderson
Journal of the American College of Cardiology|February 8, 2020
Addressing the Menace of Enterococcal EndocarditisThomas M Bashore, Nicholas A Turner
Msphere|January 14, 2021
Uncovering the Harms of Treating Clostridioides difficile ColonizationChristopher R Polage, Nicholas A Turner
Antimicrobial Agents and Chemotherapy|April 27, 2019
Reply to Frange and Leruez-Ville, "Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases"Nicholas A Turner, Cameron R Wolfe
Antimicrobial Agents and Chemotherapy|May 10, 2022
Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?Ahmad Mourad, Thomas L Holland, Nicholas A Turner
Current Opinion in Infectious Diseases|July 14, 2020
Healthcare associated diarrhea, not Clostridioides difficileNicholas A Turner, Jennifer L Saullo, Christopher R Polage
Plos Pathogens|December 20, 2019
Novel and emerging sources of Clostridioides difficile infectionNicholas A Turner, Becky A Smith, Sarah S Lewis
Open Forum Infectious Diseases|March 27, 2026
Trends in Coronavirus Disease 2019 Mortality Within a US Academic Health System, 2020-2025Nicholas A Turner, Jason E Stout, Jeffrey D Jenks
Infection Control and Hospital Epidemiology|December 3, 2025
Comparison of cefazolin administered as a continuous or intermittent infusion for prophylaxis of surgical site infections in adult patients undergoing cardiac or neurologic surgeryRichard H Drew, Nicholas A Turner, Elizabeth Keil, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Infectious Disease Clinics of North America|August 9, 2025
Infection Prevention Approaches for Clostridioides difficileJesse Vance, Nicholas A Turner
Clinics in Colon and Rectal Surgery|February 28, 2020
Hospital Infection Control: <i>Clostridioides difficile</i>Nicholas A Turner, Deverick J Anderson
Journal of the American College of Cardiology|February 8, 2020
Addressing the Menace of Enterococcal EndocarditisThomas M Bashore, Nicholas A Turner
Msphere|January 14, 2021
Uncovering the Harms of Treating Clostridioides difficile ColonizationChristopher R Polage, Nicholas A Turner
Antimicrobial Agents and Chemotherapy|April 27, 2019
Reply to Frange and Leruez-Ville, "Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases"Nicholas A Turner, Cameron R Wolfe
Antimicrobial Agents and Chemotherapy|May 10, 2022
Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?Ahmad Mourad, Thomas L Holland, Nicholas A Turner
Current Opinion in Infectious Diseases|July 14, 2020
Healthcare associated diarrhea, not Clostridioides difficileNicholas A Turner, Jennifer L Saullo, Christopher R Polage
Plos Pathogens|December 20, 2019
Novel and emerging sources of Clostridioides difficile infectionNicholas A Turner, Becky A Smith, Sarah S Lewis
Open Forum Infectious Diseases|March 27, 2026
Trends in Coronavirus Disease 2019 Mortality Within a US Academic Health System, 2020-2025Nicholas A Turner, Jason E Stout, Jeffrey D Jenks
Infection Control and Hospital Epidemiology|December 3, 2025
Comparison of cefazolin administered as a continuous or intermittent infusion for prophylaxis of surgical site infections in adult patients undergoing cardiac or neurologic surgeryRichard H Drew, Nicholas A Turner, Elizabeth Keil, et al.
Pageof 9